Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,133

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

for

Glycogen Storage Disease Type Ia

Location: Houston TX, Denver CO, Durham NC, Ann Arbor MI,

Sponsor: Ultragenyx Pharmaceutical Inc

Sex: All

Age: 2+

Code: NCT06636383

Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for

Advanced Malignant Solid Neoplasm,

Location: Houston TX, New Orleans LA, Oklahoma City OK,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase 2, Recruiting

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

for

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia,

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 65

Code: NCT02115295

Phase 2, Recruiting

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

for

Ovarian Cancer

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06036810

Recruiting

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

for

Brain Malignancies, Pseudoprogression

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06199479

Phase 1, Recruiting

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

for

Pulmonary Embolism

Location: The Woodlands TX, Tyler TX, San Antonio TX,

Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT04798261

Recruiting

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

for

Synovial Sarcoma, Myxoid/Round Cell Liposarcoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 16 - 70+

Code: NCT06083883

Phase 1, Recruiting

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

for

Multiple Myeloma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT05776979

Phase 2, Recruiting

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

for

Lung Neoplasm

Location: Houston TX, Indianapolis IN, Hines IL, Miami FL,

Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT02984761

Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for

Advanced Solid Tumor, Advanced Breast Cancer,

Location: Houston TX, San Antonio TX, Irving TX, Denver CO,

Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase 1, Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

for

B-cell Acute Lymphoblastic Leukemia

Location: Houston TX, San Antonio TX, Birmingham AL,

Sponsor: Pediatric Transplantation & Cellular Therapy Consortium

Sex: All

Age: 1 - 25

Code: NCT03509961

Phase 2, Recruiting

Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell

for

Cancer of the Mouth, Oropharynx Squamous Cell Carcinoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT02663583

Recruiting

Reducing Alcohol Exposed Pregnancies

for

Alcohol Drinking

Location: Houston TX

Sponsor: New York University

Sex: Female

Age: 18+

Code: NCT05766761

Recruiting

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

for

Oncologic Complications and Emergencies

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06217783

Recruiting

Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction

for

Myocardial Infarction

Location: Houston TX, Minneapolis MN

Sponsor: Angioblast Systems

Sex: All

Age: 18+

Code: NCT00555828

Phase 1, Phase 2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for

Acute Coronary Syndrome

Location: Houston TX, Cypress TX, Kingwood TX, Victoria TX,

Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

for

Cancer, Melanoma Stage III, Melanoma Stage IV,

Location: Houston TX, El Paso TX, The Woodlands TX, Nashville TN,

Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05970497

Phase 1, Phase 2, Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

for

Neutropenia

Location: Houston TX, Dallas TX, Fort Worth TX, Memphis TN,

Sponsor: X4 Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06056297

Phase 3, Recruiting

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

for

Diffuse Intrinsic Pontine Glioma, High Grade Glioma,

Location: Houston TX

Sponsor: Baylor College of Medicine

Sex: All

Age: 1 - 25

Code: NCT04099797

Phase 1, Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

for

Systemic Lupus Erythematosus, Lupus Nephritis

Location: Houston TX, Kansas City KS, Atlanta GA, Jacksonville FL,

Sponsor: Cabaletta Bio

Sex: All

Age: 12 - 65

Code: NCT06121297

Phase 1, Phase 2, Recruiting

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City

Paid Clinical Trials Houston

Filter results

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

Interested in new trials?

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell

Reducing Alcohol Exposed Pregnancies

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus